Investigational drug · Phase 3
IN-B00009
Not approved by FDA. In 2 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Obesity &Amp; Overweight, Diabetes (DM), Diabetes Mellitus Type 2.
Phase 3Last checked: Nov 20, 2026Latest source record: Dec 29, 2025 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 3
Industry-sponsored trials
Phase 2 and 3 trials
2
2 still active
All registered trials
2
Any phase or sponsor naming "IN-B00009"
First trial start
2025
Sep 22, 2025
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "IN-B00009", any sponsor or status.
Conditions studied
As listed on its trial records.
- Obesity &Amp; Overweight
- Diabetes (DM)
- Diabetes Mellitus Type 2
Approved drugs for the same conditions: Obesity and weight management · Cardiovascular and metabolic
Largest trials
Live from ClinicalTrials.gov: studies naming "IN-B00009" as an intervention, largest first.
- Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Adults With Obesity or Overweight Without Diabetes MellitusPivotal-lookingNot yet recruiting
HK inno.N CorporationIndustry
NCT07192263 · 300 participants (planned) · Start Sep 22, 2025 · Primary completion Dec 31, 2026
Drug: IN-B00009; Placebo · For: Obesity &Amp; Overweight
- Bridge Study to Evaluate the Efficacy and Safety of IN-B00009 Injection in Patients With T2DM Inadequately Controlled by Diet and Exercise AlonePivotal-lookingNot yet recruiting
HK inno.N CorporationIndustry
NCT07308184 · 110 participants (planned) · Start Dec 2025 · Primary completion Aug 2027
Drug: IN-B00009; Placebo · For: Diabetes (DM); Diabetes Mellitus Type 2
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Also in development for Obesity &Amp; Overweight
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.